Lance Lee, CSO

Shanghai Hansoh BioMedical Co., Ltd
SHANGHAI, Shanghai, China (People's Republic)

Disclosure information not submitted.

Presentation(s):

• SAT-684 - HS-20094 (olatorepatide): A Dual Biased GLP-1 and GIP Receptor Agonist for Obesity

  Saturday, June 13, 2026
  9:30 AM - 4:30 PM CT